[ad_1]
Novartis is breathing new life against American lawyer Michael Cohen. According to US senators, the pharmaceutical company made misleading statements about its cooperation with Cohen. Novartis denies the conclusions.
(nda / awp)
As the US Senators report on the Internet concludes, their research concludes that Novartis is a longer, narrower relationship. Relations with Cohen were more marked than before.
Thus, on May 11, Novartis stated that following the signing of the agreement on March 1, 2017 and at a single meeting, it was concluded that Cohen Novartis was not Senators wrote in their report.
Phone Calls with Jimenez
However, documents received from Senators now indicate that Cohen and the then Novartis CEO, Joe Jimenez, are still communicating several times. have. There were at least four phone calls between April and September and several emails were exchanged.
Senators also concluded that Novartis hired Cohen to gain access to key politicians. According to the document, Novartis provided the lawyer with recommendations on drug prices
Meanwhile, the pharmaceutical company maintains its previous statements. It has received requests from senators and cooperates with them, according to information provided by Novartis, which are also available AWP. In addition, the group maintains that after only one meeting with Cohen, he came to the conclusion that he can not provide the services that he hopes.
The only additional communication with Cohen was when Cohen turned several times to Jimenez, On one of those occasions, Cohen asked the CEO of the time for ideas for the lower prices of medicines.
One – year contract
Novartis admitted in early May and February 2017 a one – year contract with Essential Consultants, Michael Trump 's private attorney. have closed at more than $ 1.2 million. The same account had also been used to pay pornographic pornographic payments to Stormy Daniels porn actress.
The Office of the US Special Investigator Robert Mueller had contacted Novartis in November of last year. As a result, Novartis' chief counsel, Felix Ehrat, had to resign from his post.
Source link